Featured Resources

Introducing: LifeScienceXchange

Patients are counting on your R&D community for the next wave of life-saving medicines.

LifeScienceXchange is the catalyst: a platform for leaders from diverse life science disciplines to connect, learn and collaborate, so that together we bring new treatments to patients faster, sustainably and at scale.

Providing actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format.

It will help you understand trends, benchmark your work, inform strategy and ultimately get your new treatments to patients, faster.

Precision Medicine on LifeScienceXchange provides the events and channels for R&D to unlock human data for precise, patient-centric solutions.

LSX Logo - Better Patient Slogan

Learn faster and put new ideas to work

Market Insights unlock key learnings and actionable ideas from our industry-leading live events. We’ve cut and curated more than 6,000 hours of live recordings into quick-watch cuts, so you can get straight to the moments that matter.

Innovate sooner and benchmark success

Our Technology Showcases give you first sight of the breakthroughs driving our industry. We put you in touch with new developments and vendor success stories, so you can understand the tech, connect with the innovators and benchmark your work against the best

Learn and share ideas with industry leaders

Our Thought Leadership opportunities put you at the heart of the conversations accelerating life sciences R&D today. Hear interviews and presentations with key opinion leaders each month — and join the conversation by putting your questions to them live.

Get the full picture faster

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. Each week we identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture.

Clinical Development

Biomarkers for NASH Symposium: Most Anticipated Presentation

Discover key event highlights from Oxford Global's upcoming Biomarkers for NASH Symposium 2022.
Clinical Development

Scientists at Stanford Medicine Predict Who Will Develop Vaccine Immunity

A gene signature found in antibody-producing cells could accelerate vaccine development.
Biomarker Discovery & Development

New Therapeutic Target for Aggressive Breast Cancer

Scientists at VCU Massey Cancer Center pinpoint druggable target in aggressive breast cancer.
Digital Biomarkers

Digital Biomarkers for Disease Detection and Monitoring

Beverley Patterson, Clinical Science Director at Ono Pharma UK Ltd, leads a Discussion Group on harnessing biomarker technologies to improve disease detection and tracking.
Spatial Analysis

Spatial Omics Technologies: Spatial Proteomics, Mass Spectrometry, and Imaging Data Uses

Visualising and monitoring protein localisation requires a high degree of accuracy in image processing. Fortunately, spatial proteomics is proving itself to be an imaging technique which is more than up to the challenge.
Diagnostic Development

Genetic Variants Linked to Dyslexia

A new study from the University of Edinburgh has identified potential gene indications associated with dyslexia.
Genome Editing

Building on a New Approach to Validate Gene Editing and Localize CAR Cassettes in T Cells

On-Demand Webinar featuring Dr. Peter Mouritzen, Vice President of Application and Market Development at Samplix ApS

Oxford Global's R&D Key 40 Stories 2022

Download a copy of the R&D Key 40 Stories 2022 eBook today
Spatial Analysis

Proteomics and Metabolomics: The Role of Cellular Microenvironment in Driving Tumour Progression and Metabolomic Fingerprint

Some of the investigative methods explored in this article include mass spectrometry imaging and cell modelling of tumour architecture.
Diagnostic Development

Thirdhand Smoke Triggers Skin Disease

New research suggests acute exposure to thirdhand smoke elevates biomarkers associated with skin diseases.
Digital Biomarkers

Digital Biomarkers: Using Smartphones for the Passive Monitoring of Neurodegenerative Diseases

Smartphones, laptops and other household electronic devices could be optimised for the early detection of neurodegenerative diseases such as Alzheimer’s. Preventative monitoring approaches such as these could provide another avenue of detection to abet the provision of treatment.
Diagnostic Development

Towards Improved Biomarker Analysis and Validation

Key opinion leaders talk understanding the scientific and regulatory considerations for the qualification of biomarkers.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery